Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 474,000 | 686,000 | 143,000 | 126,000 | 175,000 |
Receivables | 1,322,000 | 1,210,000 | 1,281,000 | 1,235,000 | 1,254,000 |
Inventories | 181,000 | 190,000 | 184,000 | 184,000 | 190,000 |
TOTAL | $2,228,000 | $2,372,000 | $1,815,000 | $1,733,000 | $1,814,000 |
Non-Current Assets | |||||
PPE Net | 1,810,000 | 1,816,000 | 1,830,000 | 1,814,000 | 1,795,000 |
Investments And Advances | 133,000 | 135,000 | 130,000 | 135,000 | 128,000 |
Intangibles | 9,022,000 | 8,899,000 | 8,951,000 | 8,980,000 | 8,318,000 |
Other Non-Current Assets | 761,000 | 800,000 | 756,000 | 763,000 | 739,000 |
TOTAL | $11,726,000 | $11,650,000 | $11,667,000 | $11,692,000 | $10,980,000 |
Total Assets | $13,954,000 | $14,022,000 | $13,482,000 | $13,425,000 | $12,794,000 |
Liabilities | |||||
Current Liabilities | |||||
Short Term Debt | 906,000 | 303,000 | 304,000 | 518,000 | 2,000 |
Accounts payable and accrued liabilities | 1,239,000 | 1,359,000 | 1,157,000 | 1,201,000 | 1,198,000 |
TOTAL | $2,298,000 | $1,815,000 | $1,618,000 | $1,875,000 | $1,355,000 |
Non-Current Liabilities | |||||
Long Term Debt | 3,804,000 | 4,410,000 | 3,946,000 | 3,777,000 | 3,975,000 |
Other Non-Current Liabilities | 1,369,000 | 1,442,000 | 1,443,000 | 1,472,000 | 1,361,000 |
TOTAL | $5,187,000 | $5,865,000 | $5,401,000 | $5,263,000 | $5,351,000 |
Total Liabilities | $7,485,000 | $7,680,000 | $7,019,000 | $7,138,000 | $6,706,000 |
Shareholders' Equity | |||||
Shares Outstanding, K | 111,092 | 110,707 | 112,435 | 112,235 | 112,009 |
Common Shares | 2,000 | 2,000 | 2,000 | 2,000 | 2,000 |
Retained earnings | 8,935,000 | 8,825,000 | 8,711,000 | 8,566,000 | 8,412,000 |
Other shareholders' equity | 21,000 | 21,000 | 18,000 | 22,000 | 20,000 |
TOTAL | $6,469,000 | $6,342,000 | $6,463,000 | $6,287,000 | $6,088,000 |
Total Liabilities And Equity | $13,954,000 | $14,022,000 | $13,482,000 | $13,425,000 | $12,794,000 |